Lexicon Pharmaceuticals
LXRX
#6582
Rank
$0.88 B
Marketcap
$2.00
Share price
-0.99%
Change (1 day)
73.91%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$1.37 M-88.95%
2025$12.43 M-38.43%
2024$20.19 M111.04%
2023$9.57 M315.88%
2022$2.3 M-91.22%
2021$26.2 M1.63%
2020$25.78 M21.18%
2019$21.27 M-6.95%
2018$22.86 M-27.5%
2017$31.53 M18.35%
2016$26.64 M59.83%
2015$16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
$40.34 M$74.78 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$64.19 M$87.81 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$3.1 M$15.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$5.36 M$10.92 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$6.89 M$17.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$3.99 M$22.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/A$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$3.56 M$16.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/A$4.63 M๐Ÿ‡บ๐Ÿ‡ธ USA